Key Insights

Highlights

Treatment Research

1 treatments under study, led by Cadvec

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03740256Phase 1Recruiting

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

Showing all 1 trials

Research Network

Common Treatments

  • Cadvec1

Active Sponsors

  • Baylor College of Medicine1
  • The Methodist Hospital Research Institute1

Top Investigators

Related Conditions

  • Pancreatic Adenocarcinoma1
  • Esophageal Cancer1
  • Head And Neck Squamous Cell Carcinoma1
  • Colorectal Cancer1
  • Breast Cancer1

Activity Timeline